Clinical Conversations: How JAK Inhibitors are Changing the AD Treatment Landscape
Tolerability of JAK Inhibitors Used in Dermatology
Matthew J. Zirwas, MD
Adelaide Hebert, MD
Clinical Conversations: Risks vs Benefits of JAK Inhibitors
Clinical Conversations: The Data for JAK Inhibitors in AD
Brad Glick, DO, MPH
Raj Chovatiya, MD, PhD
Clinical Conversations: MOA of JAK Inhibitors in Dermatology
Loading...
Stay current with the best on medical education
We’re glad to see you’re enjoying PracticalDermatology… but how about a more personalized experience?
Press cancel to remain on PracticalDermatology. Press the link below or the continue button to keep going.